SIRT1 and myeloid sarcoma: Together, our findings demonstrate that Sirt1 expression in reactive astrocytes played a pathogenic role in inflammatory demyelination, and its inactivation in these cells may represent a strategy for the treatment of CNS-specific EAE and MS.